Veru - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsVeru

Veru(VERU)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

colorectal neoplasms

,

stomach neoplasms

,

gastrointestinal neoplasms

,

biliary tract neoplasms

,

,

urinary bladder neoplasms

,

invasive hydatidiform mole

,

urologic neoplasms

,

brain neoplasms

,

neoplasm metastasis

,

,

transitional cell carcinoma

,

castration-resistant prostatic neoplasms

,

,

pancreatic neoplasms

,

esophageal neoplasms

,

squamous cell carcinoma of head and neck

,

uterine cervical neoplasms

,

small cell lung carcinoma

,

ovarian epithelial carcinoma

,

ovarian neoplasms

,

salivary gland neoplasms

,

thyroid neoplasms

,

thyroid diseases

,

prostatic neoplasms

,

renal cell carcinoma

,

hepatocellular carcinoma

,

liver neoplasms

,

,

male breast neoplasms

,

anaplastic thyroid carcinoma

,

,

thymus neoplasms

,

squamous cell carcinoma

,

esophageal squamous cell carcinoma

,

malignant mesothelioma

,

,

,

mouth neoplasms

,

oropharyngeal neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

breast neoplasms

,

triple negative breast neoplasms

,

non-small-cell lung carcinoma

,

endometrial neoplasms

,

,

urinary incontinence

,

stress urinary incontinence

,

,

triple negative breast neoplasms

,

,

breast neoplasms

,

muscular atrophy

,

wasting syndrome

,

,

non-small-cell lung carcinoma

,

Aglatimagene besadenovec

,

,

triple negative breast neoplasms

,

,

pharmacokinetics

,

healthy volunteers/patients

,

pharmacological phenomena

,

breast neoplasms

,

,

,

ovarian neoplasms

,

pancreatic neoplasms

,

non-small-cell lung carcinoma

,

colorectal neoplasms

,

uterine cervical neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

urinary bladder neoplasms

,

small cell lung carcinoma

,

biliary tract neoplasms

,

,

,

hereditary sensory and autonomic neuropathies

,

hereditary breast and ovarian cancer syndrome

,

,

fallopian tube neoplasms

,

,

head and neck neoplasms

,

dna repair-deficiency disorders

,

,

x-linked bulbo-spinal atrophy

,

neoplasm metastasis

,

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

,

hepatocellular carcinoma

,

liver neoplasms

breast neoplasms

,

respiratory distress syndrome

,

acute lung injury

,

newborn respiratory distress syndrome

,

,

triple negative breast neoplasms

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

severe acute respiratory syndrome

,

,

pharmacokinetics

,

therapeutic equivalency

,

drug interactions

,

renal insufficiency

,

healthy volunteers/patients

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

,

neoplasm metastasis

,

breast neoplasms

,

,

,

diabetes mellitus

,

type 2 diabetes mellitus

,

insulin resistance

,

chronic hepatitis c

,

,

,

non-alcoholic fatty liver disease

,

,

type 1 diabetes mellitus

,

,

type 1 diabetes mellitus

,

,

diabetes mellitus

healthy volunteers/patients

,

pancreatic neoplasms

,

,

precursor b-cell lymphoblastic leukemia-lymphoma

,

castration-resistant prostatic neoplasms

,

endometrioid carcinoma

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

,

endometrial neoplasms

,

colorectal neoplasms

,

urinary bladder neoplasms

,

unknown primary neoplasms

,

pancreatic ductal carcinoma

,

,

hepatic insufficiency

,

renal insufficiency

,

myelodysplastic syndromes

,

,

,

non-small-cell lung carcinoma

,

,

,

triple negative breast neoplasms

,

multiple myeloma

,

head and neck neoplasms

,

ovarian neoplasms

,

non-hodgkin lymphoma

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

mantle-cell lymphoma

,

,

renal cell carcinoma

,

squamous cell carcinoma

,

squamous cell neoplasms

,

lymphoid leukemia

,

ovarian epithelial carcinoma

,

kidney neoplasms

,

plasma cell neoplasms

,

colonic neoplasms

,

,

,

medulloblastoma

,

,

,

rhabdomyosarcoma

,

diffuse intrinsic pontine glioma

,

small cell lung carcinoma

,

intraductal carcinoma noninfiltrating

,

b-cell lymphoma

,

prostatic neoplasms

,

brain neoplasms

,

,

oligodendroglioma

,

transitional cell carcinoma

,

myeloid leukemia acute

,

myeloid leukemia

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

,

,

kidney diseases

,

urologic neoplasms

,

urogenital neoplasms

,

urologic diseases

,

neoplasms by site

,

glandular and epithelial neoplasms

,

,

squamous cell carcinoma of head and neck

,

neoplasm metastasis

,

male breast neoplasms

,

,

unilateral breast neoplasms

,

breast neoplasms

,

Enclomiphene citrate

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use